ATRX and cancer: Genetically, ALT positive cancers frequently harbor inactivating mutations in the gene loci of α-thalassemia/mental retardation syndrome X-linked (ATRX), Death domain associated protein (DAXX), and H3 histone family member 3A (H3F3A/H3.3) [6, 13, 14].